According to Harrow Health's latest financial reports the company has $82.76 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.10 B | 101.02% |
2021-12-31 | $50.67 M | 55.64% |
2020-12-31 | $32.55 M | 8.7% |
2019-12-31 | $29.94 M | 6.74% |
2018-12-31 | $28.05 M | 598.13% |
2017-12-31 | $4.01 M | -54.6% |
2016-12-31 | $8.85 M | 229.72% |
2015-12-31 | $2.68 M | -67.3% |
2014-12-31 | $8.21 M | -47.3% |
2013-12-31 | $15.57 M | 55.24% |
2012-12-31 | $10.03 M | 6766.18% |
2011-12-31 | $0.14 M | -49.85% |
2010-12-31 | $0.29 M | -81.67% |
2009-12-31 | $1.58 M | -68.9% |
2008-12-31 | $5.11 M | 37.9% |
2007-12-31 | $3.7 M | |
2007-05-31 | $0.01 M | -57.49% |
2006-05-31 | $0.03 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | 15.85% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.82 M | -74.84% | ๐บ๐ธ USA |